Clinical Trial Update: Safety and Efficacy Study of Sivopixant, Acetazolamide and SASS-001 in Sleep Apnea [Phase 2]

View source ↗

Summary

Phase 2 safety and efficacy trial evaluating sivopixant, acetazolamide, and SASS-001 for obstructive sleep apnea is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea

Drugs mentioned

• ACETAZOLAMIDE (acetazolamide)
• SASS-001 (SASS-001)
• Sivopixant (sivopixant)

Snippet

Sponsor: Apnimed | Conditions: Sleep Apnea | Phase 2 | Status: RECRUITING